Arthropod-born viruses constitute important causative agents of emerging hemorrhagic fever diseases. In the past period of support from the Northeast Biodefense Center (NBC) we have demonstrated the presence of viral proteins that antagonize type I IFN-mediated innate immune responses encoded by dengue virus (DENV), the most significant arbovirus pathogen in humans, and Crimean-Congo hemorrhagic fever virus (CCHFV), a tick-born virus of high lethality in humans, and started the characterization of their mechanism of action in virus-infected cells. While DENV encodes multiple proteins responsible for inhibition of type IIFN signaling, one of the most striking features in DENV-infected cells with respect to this signaling pathway is the disappearance of STAT2, a transcription factor required for IFN signaling. Our preliminary data obtained during the last year of support from NBC indicate that the NS5 protein of dengue DENV, known to be the viral RNA-dependent RNA polymerase of this positive strand RNA virus, mediates STAT2 degradation after undergoing proteolytical maturation from the precursor viral polyprotein. In addition, we have described the presence of a protease motif associated with the amino-terminus of the L protein of CCHFV, also known to be the viral RNA-dependent RNA polymerase of this negative strand RNA virus, that removes ubiquitin and the IFN-induced ubiquitin-like molecule ISG15 from conjugated cellular substrates, inhibiting antiviral innate immune responses. During the next period, we now propose to investigate at the molecular level the mechanisms by how these two different viral proteins achieve their inhibitory effects of the host antiviral response, to evaluate the impact of these inhibitory mechanisms in viral pathogenesis and to establish assays for the screening of small compounds that inhibit DENV and CCHFV antagonism of innate immunity, decreasing viral replication and disease. Part of these studies will be performed in collaboration with other projects of the NBC. Our proposed experiments will increase our understanding of viral innate immunity, help with the possible development of an improved DENV mouse model, and hopefully identify new classes of inhibitors for these two hemorrhagic fever viruses.

Public Health Relevance

Dengue virus and Crimean-Congo hemorrhagic fever viruses are category A and C pathogens for which no antivirals and no vaccines are currently available. Our studies aim to identify novel antivirals against these viruses, taking advantage of our previous knowledge on viral antagonism of the IFN response and of interactions with other members of the Northeast Biodefense Center.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-DDS-M)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Columbia University (N.Y.)
New York
United States
Zip Code
Johnson, Joshua C; Martinez, Osvaldo; Honko, Anna N et al. (2014) Pyridinyl imidazole inhibitors of p38 MAP kinase impair viral entry and reduce cytokine induction by Zaire ebolavirus in human dendritic cells. Antiviral Res 107:102-9
Gough, Daniel J; MariƩ, Isabelle J; Lobry, Camille et al. (2014) STAT3 supports experimental K-RasG12D-induced murine myeloproliferative neoplasms dependent on serine phosphorylation. Blood 124:2252-61
Kazakov, Teymur; Kuznedelov, Konstantin; Semenova, Ekaterina et al. (2014) The RimL transacetylase provides resistance to translation inhibitor microcin C. J Bacteriol 196:3377-85
Rajsbaum, Ricardo; Garcia-Sastre, Adolfo; Versteeg, Gijs A (2014) TRIMmunity: the roles of the TRIM E3-ubiquitin ligase family in innate antiviral immunity. J Mol Biol 426:1265-84
Lo, Michael K; Bird, Brian H; Chattopadhyay, Anasuya et al. (2014) Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrian hamsters. Antiviral Res 101:26-9
Mackow, Erich R; Dalrymple, Nadine A; Cimica, Velasco et al. (2014) Hantavirus interferon regulation and virulence determinants. Virus Res 187:65-71
Varshney, Avanish K; Wang, Xiaobo; Aguilar, Jorge L et al. (2014) Isotype switching increases efficacy of antibody protection against staphylococcal enterotoxin B-induced lethal shock and Staphylococcus aureus sepsis in mice. MBio 5:e01007-14
Chung, Lawton K; Philip, Naomi H; Schmidt, Valentina A et al. (2014) IQGAP1 is important for activation of caspase-1 in macrophages and is targeted by Yersinia pestis type III effector YopM. MBio 5:e01402-14
DiLillo, David J; Tan, Gene S; Palese, Peter et al. (2014) Broadly neutralizing hemagglutinin stalk-specific antibodies require Fc?R interactions for protection against influenza virus in vivo. Nat Med 20:143-51
Szaba, Frank M; Kummer, Lawrence W; Duso, Debra K et al. (2014) TNF? and IFN? but not perforin are critical for CD8 T cell-mediated protection against pulmonary Yersinia pestis infection. PLoS Pathog 10:e1004142

Showing the most recent 10 out of 549 publications